RTRAF and cervical carcinoma: Kaplan–Meier survival analysis and the log-rank test indicated that a high level of C14ORF166 protein expression was associated with significantly poorer 5-year overall survival (OS, P < 0.001; Fig. 4a) and 5-year disease-free survival (DFS, P < 0.001; Fig. 4b) in patients with cervical cancer.